AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol (December 5, 2007). doi:10.1152/ajprenal.00436.2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/2/F433    most recent
00436.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bing, Y.
Right arrow Articles by Zhang, M.-Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bing, Y.
Right arrow Articles by Zhang, M.-Z.
Submitted on September 17, 2007
Accepted on December 3, 2007

Renal Localization and Regulation of 15-Hydroxyprostaglandin Dehydrogenase

Yao Bing1, Jie Xu2, Raymond C. Harris3*, and Ming-Zhi Zhang4

1 Medicine, Division of Nephrology, Vanderbilt University, Nashville, Tennessee, United States; Medicine, Division of Nephrology, Vanderbilt University School of Medicine, Nashville, Tennessee, United States
2 Medicine, Division of Nephrology, Vanderbilt University School of Medicine, Nashville, Tennessee, United States
3 Medicine, Division of Nephrology, Vanderbilt University School of Medicine, nashville, Tennessee, United States
4 Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, United States; Medicine, Division of Nephrology, Vanderbilt University School of Medicine, Nashville, Tennessee, United States

* To whom correspondence should be addressed. E-mail: ray.harris{at}vanderbilt.edu.

Tissue prostaglandin levels are determined by both biosynthesis and catabolism. The current studies report the expression and localization of 15-hydroxyprostaglandin dehydrogenase (15-PGDH), a key enzyme in prostaglandin catabolism in the kidneys. We also investigated potential interactions between 15-PGDH and cyclooxygenase (COX), a key enzyme in prostaglandin biosynthesis. Both 15-PGDH mRNA and protein levels were significantly higher in kidney cortex than papilla, which is opposite to the expression pattern of COX-2. In situ hybridization indicated that 15-PGDH mRNA was mainly localized to the tubular epithelial cells in kidney cortex and outer medulla, but not in the glomerulus or papilla. Dual immunofluorescent staining indicated that 15-PGDH was expressed in the proximal tubule, medullary and cortical thick ascending limbs and cortical and outer medullary collecting duct but not in the macula densa or papilla. 15-PGDH levels were significantly lower in a macula densa cell line (MMDD1) than a proximal tubule cell line. Although a high salt-diet decreased COX-2 expression in macula densa, it increased macula densa 15-PGDH expression in both mouse and rat kidneys. In MMDD1 cells, a COX-2 inhibitor increased 15-PGDH while a COX-1 inhibitor had no effect. Furthermore, intense 15-PGDH immunofluorescent staining was found in both macula densa and glomerulus in COX-2 knockout mice. The intrarenal distribution of 15-PGDH and its interactions with COX-2 suggest that differential regulation of COX-2 and 15-PGDH may play an important role in determining levels of prostaglandins involved in regulation of salt, volume, and blood pressure homeostasis.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.